Carl Magnus Högerkorp
No más puestos en curso
Historial de carrera de Carl Magnus Högerkorp
Antiguos cargos conocidos de Carl Magnus Högerkorp.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Director Ejecutivo | 01/01/2019 | 01/04/2021 |
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Director Ejecutivo | 01/05/2017 | 01/10/2018 |
| XINTELA AB | Director Técnico/Científico/I+D | 01/01/2016 | 01/04/2017 |
| Immodulate Pharma AB | Director Ejecutivo | 01/01/2021 | - |
| Fundador | 01/01/2021 | - | |
| CYXONE AB | Director/Miembro de la Junta | 01/01/2023 | - |
| Director Ejecutivo | 20/06/2022 | - | |
| Director de Operaciones | 20/05/2021 | 13/12/2022 | |
| Contacto de Relaciones con Inversores | - | - |
Formación de Carl Magnus Högerkorp.
| University of Lund | Doctorate Degree |
| Lund University School of Economics & Management | Masters Business Admin |
Estadísticas
Internacional
| Suecia | 8 |
Operativa
| Chief Executive Officer | 4 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| XINTELA AB | Health Technology |
| CYXONE AB | Health Technology |
| Empresas privadas | 3 |
|---|---|
Edvince AB
Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Health Technology |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
| Immodulate Pharma AB |
